William McKee, Chief Financial Officer at C4 Therapeutics, Inc. (CCCC), bought 5,263 shares at $19.00 ($100K) on 2020-10-06, disclosed to the SEC on 2020-10-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ASRT | SELL | 2019-05-09 | $59K | — | Filing → |
| ASRT | SELL | 2018-12-17 | $41K | — | Filing → |
| AUXL | SELL | 2014-12-08 | $612K | — | Filing → |